ZoomInfo, Pliant Therapeutics Bulk Up IPOs Before Pricing
Sales and marketing intelligence company ZoomInfo and biopharmaceutical company Pliant Therapeutics on Tuesday upsized their expectations for their upcoming initial public offerings, with ZoomInfo saying it now expects an $868 million...To view the full article, register now.
Already a subscriber? Click here to view full article